Bindoff LA, Birch-Machin MA, Farnsworth L, Gardner-Medwin D, Lindsay JG, Turnbull DM. Familial intermittent ataxia due to a defect of the E1 component of pyruvate dehydrogenase complex. J Neurol Sc 1989; 93: 311-318
Blass JP, Avigan J, Uhlendorf BW. A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 1970; 49: 423-432
Brown GK, Haan EA, Kirby DM, Scholem RD, Wraith JE, Rogers JG et al. Cerebral lactic acidosis: defects in pyruvate metabolism with profound brain damage and minimal systemic acidosis. Eur J Pediatr 1988; 147: 10-14
Cameron JM, Levandovskiy V, Mackay N, Tein I, Robinson BH. Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1 alpha gene. Am J Med Genet A 2004; 131: 59-66
Debray FG, Lambert M, Vanasse M, Decarie JC, Cameron J, Levandovskiy V et al. Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr 2006; 165: 462-466
Debray FG, Mitchell GA, Allard P, Robinson BH, Hanley JA, Lambert M. Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. Clin Chem 2007; 53: 916-921
Head RA, Goede CG de, Newton RW, Walter JH, MacShane M, Brown RM et al. Pyruvate dehydrogenase deficiency presenting as dystonia in childhood. Dev Med Child Neurol 2004; 46: 710-712
Lissens W, DeMeirleir L, Seneca S, Liebars I, Brown GK, Brown RM et al. Mutation in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 2000; 15: 209-219
Livingstone IR, Gardner-Medwin D, Pennington RJ. Familial intermittent ataxia with possible X-linked recessive inheritance. Two patient with abnormal abnormal pyruvate metabolism and a response to acetazolamide. J Neurol Sci 1984; 64: 89-97
Marsac C, Beneli C, Desguerre I, Diry M, Fouque F, Meirleir L De et al. Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency. Hum Genet 1997; 99: 785-792
Mellick G, Price L, Boyle R. Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord 2004; 19: 727-729
Naito E, Ito M, Yokota I, Saijo T, Ogawa Y, Kuroda Y. Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 2002; 201: 33-37
Naito E, Ito M, Yokota I, Saijo T, Matsuda J, Ogawa Y et al. Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region. Biochem Biophys Acta 2002; 1588: 79-84
Old SE, DeVivo DC. Pyruvate dehydrogenase complex deficiency: biochemical and immunoblot analysis of cultured skin fibroblasts. Ann Neurol 1989; 26: 746-751
Robinson BH, MacMillan H, Petrova-Benedict R, Sherwood WG. Variable clinical presentation with defective E1 component of the pyruvate dehydrogenase complex. J Pediatr 1987; 111: 525-533
Robinson BH. Lactic acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, (eds). The metabolic and molecular bases of inherited disease 8th edn. New York: McGraw-Hill 2001; 2275-2295
Seyda A, MacEachern G, Haas R, Robinson BH. Sequential deletion of C-terminal amino acids of the E(1)alpha component of the PDH complex leads to reduced steady-state levels of functional E(1)alpha(2)beta(2) tetramers:implications for patients with PDH deficiency. Hum Mol Genet 2000; 9: 1041-1048
Sheu KF, Hu CW, Utter MF. Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts. J Clin Invest 1981; 67: 1463-1471
Strassburg HM, Koch J, Mayr J, Sperl W, Bolthauser E. Acute flaccid paralysis as initial symptom in 4 patients with novel E1a mutations of the pyruvate dehydrogenase complex. Neuropediatrics 2006; 37: 137-141
